Young Investigator Reneo Pharmaceuticals 20. maj 2019 Reneo Pharmaceuticals Raises $50 Million to Develop Therapeutics to Treat Genetic Mitochondrial Diseases Lundbeckfonden Ventures 17. maj 2016 Ziarco Pharma Announces Positive Top Line Results from Phase 2a Study in Moderate to Severe Atopic Dermatitis with its Oral Lead Compound ZPL-389
